Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Axsome Therapeutics Inc. (AXSM)

78   -3.66 (-4.48%) 02-28 16:00
Open: 78.57 Pre. Close: 81.66
High: 81.9899 Low: 74.571
Volume: 1,158,429 Market Cap: 2887M
Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focusses on developing novel therapeutics for the redressal of diseases related to the central nervous system.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 82.525 - 83.317 83.317 - 83.796
Low: 72.994 - 73.964 73.964 - 74.55
Close: 76.851 - 78.482 78.482 - 79.469

Technical analysis

as of: 2020-02-28 4:26:32 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 104.35     One year: 115.01
Support: Support1: 74.57    Support2: 62.04
Resistance: Resistance1: 89.34    Resistance2: 98.47
Pivot: 88.64
Moving Average: MA(5): 83.35     MA(20): 89.60
MA(100): 61.08     MA(250): 37.25
MACD: MACD(12,26): -1.23     Signal(9): 0.54
Stochastic oscillator: %K(14,3): 15.49     %D(3): 12.58
RSI: RSI(14): 32.59
52-week: High: 109.94  Low: 8.11  Change(%): 863.0
Average Vol(K): 3-Month: 125604  10-Days: 68849

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AXSM has closed below the lower band by 10.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 22.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 27 Feb 2020 17:28:00 +0000
Sage Therapeutics Disappoints With Its Q4 Report

Sat, 22 Feb 2020 15:00:00 +0000
These 2 Stocks Could Be 2020's Best Profit Opportunities

Mon, 17 Feb 2020 14:57:00 +0000
6 Healthcare Stocks That Could Make You Filthy Rich

Wed, 15 Jan 2020 18:25:47 +0000
Ocugen Stock Is Not for the Faint of Heart

Wed, 15 Jan 2020 12:02:00 +0000
Are Biotech Stocks Due for a Correction in 2020?

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.02
Shares Float (M) 24.44
% Held by Insiders 22.30
% Held by Institutions 62.13
Shares Short (K) 5030
Shares Short P. Month (K)

Stock Financials

EPS -1.620
Book Value (p.s.) 0.200
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -107.6
Return on Equity (ttm) -1404.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.407
Qtrly Earnings Growth
Operating Cash Flow (M) -38.60
Levered Free Cash Flow (M) -18.70

Stock Valuations

P/E -48.15
P/E Growth Ratio -0.04
P/BV 390.00
P/CF -74.81

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.